Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia
Year: 1999
Type: article
Abstract: Cell lines RPMI 8226, JJN3, U266 B1, NCI-H929 (all EBV-) and ARH77 and HS-Sultan (both EBV+) have been extensively characterized in this study. EBV- lines expressed the phenotype (CD138-, CD19+, CD20+) whereas EBV+ were (CD138+, CD19-, CD20-). CD56 expression was restricted to EBV- cell lines, with the exception of U266 B1, whereas PCA-1 was strongly expressed on five of the six cell lines. Only EBV+ cell lines bound peanut-agglutinin (PNA). However, all cell lines bound the lectin Jacalin that binds the same receptor as PNA, irrespective of the receptors sialylation status. By RT-PCR and direct sequencing of their IgH V/D/J domains, ARH77 was demonstrated to use the germline sequence VH4-34/dm1/JH6b, whereas no arrangement was demonstrated for RPMI 8226, suggesting IgH gene deletion or mutation. HLA class I and II antigens were detected using HLA typing on all cell lines warranting their use as suitable targets for HLA-restricted cytotoxic T cells. By sensitive RT-PCR, mRNA for IL-6, IL-6R and TNFbeta was found expressed in all cell lines. IL-1 mRNA expression was predominantly associated with the EBV+ phenotype. Although mRNA for IL-3 and GM-CSF was never detected, transcripts for c-kit ligand and, more commonly, its receptor were. Likewise GM-CSF, M-CSF and erythropoietin mRNA transcripts were detected in the majority of cell lines.
Source: British Journal of Haematology
Authors: R. P. Gooding, A. Bybee, F. Cooke, A. Little, S. G. E. Marsh, E. Coelho, D. Gupta, D. Samson, J. F. Apperley
Institutions: Hammersmith Hospital, Imperial College London, Anthony Nolan
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: plasma cell dyscrasia, multiple myeloma, human myeloma cell lines, cell surface phenotype, syndecan-1, CD56, sialic acid, lectin binding, immunoglobulin heavy chain gene rearrangement, HLA typing, cytokine gene expression, interleukin-6, IL-6 receptor, lymphotoxin, interleukin-1, c-kit ligand, GM-CSF, macrophage colony-stimulating factor, erythropoietin, interleukin-3
Open Access status: bronze
Funder: Anthony Nolan
OpenAlex ID: W2004209804
